Literature DB >> 29188600

Killing two birds with one stone: The multifunctional roles of mesenchymal stem cells in the treatment of neurodegenerative and muscle diseases.

Na Kyung Lee1,2,3,4, Duk L Na1,2,3,4, Jong Wook Chang1,5.   

Abstract

Neurodegenerative and muscle diseases bear both complex and multifactorial pathologies. An efficacious and robust therapeutic option to treat these diseases is yet to be elucidated. At such a time, mesenchymal stem cells have drawn significant attention due to their immunomodulatory and regenerative properties. Accumulating evidence has proposed the capability of MSCs to serve multiple roles in a broad spectrum of diseases by secretion of trophic or paracrine factors. In the present review, we will look into the recent literature and discuss the therapeutic functions of MSCs and their potential to treat various neurodegenerative (Alzheimer's, Parkinson's, and Huntington's disease) and muscle (Duchenne muscular dystrophy, myopathy, and multiple sclerosis) diseases.

Entities:  

Mesh:

Year:  2017        PMID: 29188600     DOI: 10.14670/HH-11-951

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  7 in total

Review 1.  Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).

Authors:  Marina Devetzi; Maria Goulielmaki; Nicolas Khoury; Demetrios A Spandidos; Georgia Sotiropoulou; Ioannis Christodoulou; Vassilis Zoumpourlis
Journal:  Int J Mol Med       Date:  2018-01-03       Impact factor: 4.101

2.  A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain.

Authors:  Jung Won Hwang; Na Kyung Lee; Je Hoon Yang; Hyo Jin Son; Sa Ik Bang; Jong Wook Chang; Duk L Na
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

3.  Exposure of Mesenchymal Stem Cells to an Alzheimer's Disease Environment Enhances Therapeutic Effects.

Authors:  Sang Eon Park; Hyeong Seop Kim; Soo Jin Kwon; Min-Jeong Kim; Suk-Joo Choi; Soo-Young Oh; Gyu Ha Ryu; Hong Bae Jeon; Duk L Na; Jong Wook Chang
Journal:  Stem Cells Int       Date:  2021-03-16       Impact factor: 5.443

4.  Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial.

Authors:  Hee Jin Kim; Kyung Rae Cho; Hyemin Jang; Na Kyung Lee; Young Hee Jung; Jun Pyo Kim; Jung Il Lee; Jong Wook Chang; Seongbeom Park; Sung Tae Kim; Seung Whan Moon; Sang Won Seo; Soo Jin Choi; Duk L Na
Journal:  Alzheimers Res Ther       Date:  2021-09-14       Impact factor: 6.982

5.  Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer's Disease.

Authors:  Na Kyung Lee; Su Hyeon Myeong; Jung Won Hwang; Jason K Sa; Hyo Jin Son; Hee Jin Kim; Hyemin Jang; Jong Wook Chang; Duk L Na
Journal:  Biomedicines       Date:  2022-08-04

6.  Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment.

Authors:  Na Kyung Lee; Hyeongseop Kim; Jong Wook Chang; Hyemin Jang; Hunnyun Kim; Jehoon Yang; Jeyun Kim; Jeong Pyo Son; Duk L Na
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

7.  Anti-Fibrotic Effect of Human Wharton's Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1.

Authors:  Alee Choi; Sang Eon Park; Jang Bin Jeong; Suk-Joo Choi; Soo-Young Oh; Gyu Ha Ryu; Jeehun Lee; Hong Bae Jeon; Jong Wook Chang
Journal:  Int J Mol Sci       Date:  2020-08-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.